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Abstract
Background: Neuropsychiatric symptoms (NPS) frequently occur in patients with dementia. To date, prospective
studies on the course of NPS have been conducted in patients with dementia in clinical centers or psychiatric
services. The primary goal of this study is to investigate the course of NPS in patients with dementia and caregiver
distress in primary care. We also aim to detect determinants of both the course of NPS in patients with dementia
and informal caregiver distress in primary care.
Methods/design: This is a prospective observational study on the course of NPS in patients with dementia in
primary care. Thirty-seven general practitioners (GPs) in 18 general practices were selected based on their interest in
participating in this study. We will retrieve electronic medical files of patients with dementia from these general
practices. Patients and caregivers will be followed for 18 months during the period January 2012 to December
2013. Patient characteristics will be collected at baseline. Time to death or institutionalization will be measured.
Co-morbidity will be assessed using the Charlson index. Psychotropic drug use and primary and secondary outcome
measures will be measured at 3 assessments, baseline, 9 and 18 months. The primary outcome measures are the
Neuropsychiatric Inventory score for patients with dementia and the Sense of Competence score for informal
caregivers. In addition to descriptive analyses frequency parameters will be computed. Univariate analysis will be
performed to identify determinants of the course of NPS and informal caregiver distress. All determinants will then
be tested in a multivariate regression analysis to determine their unique contribution to the course of NPS and
caregiver distress.
Discussion: The results of this study will provide data on the course of NPS, which is clinically important for
prognosis. The data will help GPs and other professionals in planning follow-up visits and in the timing for offering
psycho-education, psychosocial interventions and the provision of care. In addition, these data will enlarge health
professionals’ awareness of NPS in their patients with dementia.
Keywords: Dementia, Neuropsychiatric symptoms, Primary care, Longitudinal, Observational, Quality of life,
Caregiver distress
Background
Dementia is a chronic and mostly progressive disease
with great impact on patients and their family members.
Current estimates indicate that 35.6 million people world-
wide are living with dementia. This number is expected to
double by 2030 and more than triple by 2050 [1]. The esti-
mated standardized prevalence of dementia among per-
sons aged 60 and over in Western Europe, Central Europe
and Eastern Europe is 7.3%, 5.8% and 5.7%, respectively
[1]. In the Netherlands 250,000 people have dementia, and
most of these patients reside in the community.
Neuropsychiatric symptoms (NPS), such as psychosis
(delusions and hallucinations), depressive mood, anxiety, ir-
ritability/lability, apathy, euphoria, disinhibition, agitation/
aggression, aberrant motor activity, sleep disturbance and
eating disorder, often occur in patients with dementia.
NPS result in lower quality of life for both the patient and
caregiver and affect the quality of the patient-caregiver re-
lationship [2,3]. NPS, severity of cognitive impairment,
Alzheimer’s dementia, high rates of functional dependence
and depressive symptoms are predictors of nursing home
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admission [4]. Major depression is a predictor of early
institutionalization in the first year following the dementia
diagnosis [5]. The baseline severity of NPS, stage of de-
mentia and use of support services predict the future se-
verity of NPS [6]. However, there is a lack of knowledge
about the determinants of neuropsychiatric symptoms in
community-dwelling patients with dementia.
Studies in various countries reported NPS prevalence
rates that ranged from 66 to 94% [7-13]. Incidence rates
of NPS were reported in only a few studies. In a United
States (US) Cache County study, Steinberg et al. found
an incidence rate of 69% after an 18-month follow-up
[14]. Only one Dutch study has been conducted on the
course of NPS in community-dwelling people with de-
mentia. In the MAASBED (MAAstricht Study of BE-
haviour in Dementia) study it was found that 81% of
the patients with dementia from a memory clinic and
an ambulatory mental health institute showed any
type of NPS, such as agitation (19%), irritability (24%), ab-
errant motor behavior (26%), depression (35%), apathy
(40%), anxiety (21%) and delusions (22%) [15]. After a
6-12-month follow-up, the cumulative incidence of
NPS was 74% [15]. Several prospective studies of NPS
in community-dwelling patients with dementia have
been conducted in other countries. In most of these
studies, the Neuropsychiatric Inventory (NPI) was used
to evaluate NPS. Eighty-one percent of those without
any NPS at baseline had at least one symptom after
18 months in the US Cache County study [16]. In the
same study, 67% of the participants with at least 1
clinically significant NPS (total NPI score ≥4) at base-
line continued to display clinically significant NPS after
18 months. Among the 10 neuropsychiatric symptoms
assessed at baseline, delusions persisted in 66%, depres-
sion in 58% and aberrant motor behavior in 56% of
the individuals. Hallucinations and disinhibition per-
sisted in 25% and 11% of the participants, respectively
[16]. In a study in the United Kingdom, 94% of the
participants had at least one NPS and 75% of the par-
ticipants had an NPI score ≥4 for at least one symp-
tom. Of the latter group, 80% had a persistent NPI
score ≥4 in at least one domain after 6 months [12]. Fur-
thermore, a 2-year follow-up study in England and Wales
showed that NPS co-occur [17]. Anxiety and depres-
sion as well as misidentification, persecution and hallu-
cinations were strongly associated [17]. The REAL-FR
(Réseau sur la Maladie d’Alzheimer Français) cohort
study found that the percentage of patients presenting
one or more clinically relevant NPS as measured by
the NPI increased from 66% at baseline to 88% after
4-year follow-up [13]. Prevalence of agitation increased
from 17.9% to 29.1%, apathy from 43.0% to 62.9%, disin-
hibition from 2.6% to 14.6%, hallucination from 2% to
4.6% and aberrant motor behavior from 13.9% to 29.1%.
Prevalence of hyperactivity and apathy increased sig-
nificantly during the follow-up, whereas the prevalence of
affective and psychotic symptoms did not increase [13].
To date, prospective studies on the course of NPS have
been conducted on ambulatory patients with dementia
in memory clinics or clinical centers [13,15], using am-
bulatory services [15] or who were approached through
local psychiatric services, the volunteer sector and nurs-
ing and residential care homes [12]. High (cumulative)
prevalence and (cumulative) incidence rates of NPS
were found in these studies. In the REAL-FR cohort,
a prevalence of 66% at baseline increased to 88% after
4 years [13]. In the MAASBED study, a prevalence of
80.9% at baseline increased to a cumulative prevalence
of 88.9% after 2 years, and the cumulative incidence after
6–12 months was 74% in ambulatory patients of memory
clinics or psychiatric services [15]. In the LASER-AD
(London And the South East Region - Alzheimer’s Disease)
study, 33% of the participants were recruited from 24-hour
care settings and 67% were living at home. The preva-
lence rates of NPS at baseline were 93.8% for at least
one NPS, and 88.4% of the participants had a NPI
score ≥ 4 in at least one domain. At 6-month follow-up,
96.2% had at least one NPS in any domain. Of these
participants 80.3% had a persistent NPI score ≥ 4 in at
least one domain [12].
Steinberg and Savva have studied a community-dwelling
population [16,17]. In Cache County, 62% of the par-
ticipants with dementia had at least one NPS at base-
line and 23% had a NPI score ≥ 4 in at least one domain.
After 18 months, 95% of the participants had at least
one NPS at baseline and 49% had a NPI score ≥ 4 in
at least one domain. However, of the 5092 individuals
who were enrolled in this study, 265 resided in nurs-
ing homes. Information was not provided on the per-
centage of the 329 participants with dementia who resided
in nursing homes [16]. In the Medical Research Council
Cognitive Function and Aging Study, prevalence rates of
5.8% for confabulation to 50.3% for apathy were found
in dementia patients. Incidence rates of 2% for anx-
iety to 61% for apathy were found after 2 years. Further-
more, persistence rates were 13% for confabulation and
66% for apathy. The percentage of participants who lived
in institutions was 38% at baseline and 66% after 2-year
follow-up.
It appears as though the prevalence and incidence
rates of NPS in community-dwelling patients with de-
mentia are lower (23% to 50% and 49% to 60% respect-
ively) than those of ambulatory patients of memory
clinics or clinical centers and ambulatory patients of psy-
chiatric services (66% to 96.2% and 74% respectively).
Finally, the relationship between caregiver characteris-
tics and caregiver distress and NPS was unclear in
these studies.
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Aims of the study
The first aim of this study is to investigate the course of
NPS in patients with dementia and informal caregiver
distress in primary care. We also aim to detect determi-
nants of both the course of NPS in patients with demen-
tia and informal caregiver distress in primary care.
Methods/design
Study design
This is a prospective observational cohort study in pri-
mary care. For this study, all 192 known general practi-
tioners (GPs) in 114 general practices in the region
West- and Middle-Brabant in the southern part of the
Netherlands were invited to participate. All GPs of the
114 practices individually received a letter with informa-
tion on the study and were invited to attend a meeting
about NPS and the study. Announcements of this study
were also posted on the websites of the regional GP cor-
porations. Thirty-seven GPs in 18 general practices were
selected based on their interest in participating in the
study. The presence of specialized care for elderly people
in the general practices will be determined by asking
whether the participating GPs followed a specialized
management training course in elderly care medicine in
primary care and whether specialized staff members are
available in these general practices to support the GP in
managing the care for elderly patients. We will retrieve
electronic medical files of patients with dementia from
these general practices. Patients and informal caregivers
will be approached by letter. Informal caregivers are per-
sons who are listed in the electronic medical files of the
GP as the main informal caregiver and contact person.
There will be no restriction in the amount of time that
the informal caregiver spends with the patient. After the
letter is mailed to the patient and informal caregiver, the
GP will contact the patient or informal caregiver by tele-
phone to stimulate participation in the study. The as-
sessment interviews will take place at the patients home
by a trained interviewer.
Patients and informal caregivers will be followed for
18 months. In case that a patient dies or will be institu-
tionalized, length of time to death or institutionalization,
respectively, will be measured. The study began in January
2012 and will end in December 2013.
In the Netherlands, many psychosocial interventions
and care services are available for community-dwelling
people with dementia, including cognitive training and
stimulation, physical exercise, reminiscence, education and
support for both patient and informal caregiver and respite
care. Dementia CM is stimulated by the Dutch govern-
ment and is available in all parts of the country. Dementia
CM involves assessment, planning and advocacy for pa-
tients with dementia and their informal caregivers. It also
aims to empower informal caregivers and facilitate timely
access to essential care services to support their caregiver
needs. In the southern region of the Netherlands, dementia
CM is provided by many care organizations and care ser-
vices. We consider this single component dementia CM.
In 14 of the participating general practices, a multicom-
ponent collaborative care program named CONCERN
(Care Optimization for Non-professional Caregivers of
Elderly with dementia and Reduction of Neuropsychiatric
symptoms) will be provided. In CONCERN, a dementia
CM together with an elderly care physician (ECP) and the
GP focus on optimization of care and improvement of
quality of life for patients with dementia suffering from
NPS and their informal caregivers. Following assessment
and diagnosis of the NPS, a care plan is designed for the
treatment and support of both the patient and informal
caregiver. This care plan is periodically evaluated in a
multidisciplinary meeting with the GP, ECP, dementia CM
and other involved care services.
We will measure whether the patients with dementia
and their informal caregivers are treated by single compo-
nent dementia CM, CONCERN or care as usual (no CM).
Patients and their informal caregivers
All patients in the participating general practices with a
diagnosis of dementia as registered in the electronic
medical files of the general practice, and living at home
are eligible to participate in this study together with
their informal caregiver (spouse, child or neighbor). We
will select patients with the International Classification
of Primary Care (ICPC) code for dementia (P70) from the
electronic medical systems. This code includes Alzheimer’s
disease and senile dementia. We will also select patients
with memory disturbance (ICPC code P20) who are diag-
nosed with dementia. Patients with an estimated life ex-
pectancy of less than 3 months will be excluded from the
current study. All patients and caregivers will receive a
complete written description of the study and be asked to
sign an informed consent document. If the patient is un-
able to provide informed consent, his or her legal represen-
tative will be asked to provide informed consent on the
patient’s behalf.
Ethical approval
This research project was presented for medical ethics
review at the Committee on Research Involving Human
Subjects (CMO) of the district Arnhem - Nijmegen, the
Netherlands. The CMO judged that the current project
is not subject to the Medical Research Involving Human
Subjects Act (WMO) and can be conducted without re-
view by the CMO.
Assessment instruments
Data are collected by a trained research assistant during
an interview with the patient and the caregiver at home
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at baseline (T0), after 9 months (T1) and at 18 months
(T2). The same set of questionnaires will be used in all 3
assessments (Table 1). The outcome measures have good
psychometric properties. The primary outcome for the
patient is the NPI and that for the informal caregiver is
the sense of competence (SCQ).
Patient characteristics
The following patient characteristics will be collected at
baseline (T0): age, gender, marital state, socio-economic
status/educational level and profession, use of health
care services (psychiatric services; home care: nursing, do-
mestic; day care services; on waiting list for residential care
facility or nursing home). Co-morbidity will be assessed
using the Charlson index (CI). The CI comprises 19
categories of International Classification of Diseases,
9th Revision, Clinical Modification (ICD-9CM) diagnose
codes and is based on a set of risk factors for 1-year
mortality risk [18]. The CI contains a weighted index
for each disease, with a score that is a significant predictor
of 1-year survival. Psychotropic drug use (antipsychotics,
anticonvulsants, antidepressants, anxiolytics, hypnotics
and medication for dementia) will be collected in all 3
assessments.
Neuropsychiatric symptoms
The Neuropsychiatric Inventory (NPI), developed by
Cummings [19,20], will be the primary outcome. This
inventory assesses 12 neuropsychiatric symptoms in de-
mentia outpatients. The validity and reliability of the NPI
[21] and of its Dutch version [22] were previously estab-
lished. Since then, the NPI has been the most widely used
rating scale for the assessment of NPS. The NPI comprises
12 categories of problem behavior, as follows: delusions,
hallucinations, agitation/aggression, depression, anxiety,
euphoria, disinhibition, irritability/lability, apathy, aberrant
motor activity, sleeping disorder and eating disorder. For
each positive symptom, the severity and frequency are
scored on the basis of structured questions administered
to the patients’ caregiver. The continuous score for each
symptom is obtained by multiplying severity (1–3) by
frequency (1–4). In line with previous studies [8,13-16],
a score of 4 or more on one symptom will be taken to in-
dicate the presence of specific ‘clinically relevant’ symp-
toms. Caregiver distress is also assessed (0–5), but is
not calculated in the NPI total score. Frequency and
severity scores of individual symptoms can be multi-
plied (FxS score) and summed over 12 items, yielding
a total NPI score that ranges from 0 to 144. The fol-
lowing five NPI factor scores (based on the findings of
previous studies) will be used [23,24]: (1) agitation, con-
sisting of agitation/aggression, euphoria, disinhibition and
irritability; (2) depression, consisting of depression and
anxiety; (3) psychosis, consisting of hallucinations and de-
lusions; (4) psychomotor agitation, consisting of aberrant
motor behavior and nighttime behavior, and (5) apathy,
consisting of apathy and eating disorder [23]. The NPI will
be assessed by a trained interviewer during an interview
with the informal caregiver.
The Cohen-Mansfield Agitation Inventory (CMAI), ori-
ginally developed by Cohen-Mansfield [25], is the most
widely used assessment scale for measuring the frequency
of agitation and aggression. This inventory defines agita-
tion as inappropriate verbal, vocal or motor activities not
explained by apparent needs or confusion. The informant
is the patient’s caregiver. Symptoms are assessed for the
preceding 2 weeks. The original and translated Dutch
version were found to be valid and reliable [26-28]. It
consists of 29 individual items and can be categorized
in 3 subscales, which assess physically aggressive (directed
against a person or object), physically non-aggressive (not
directed against a person or object, such as pacing and
wandering) and verbally agitated behavior. Items are
scored on a 7-point frequency scale, as follows: 1 = never;
2 = < once a week; 3 = 1–2 times per week; 4 = several
times per week; 5 = 1–2 times per day; 6 = several times
per day; 7 = several times per hour [26]. In community-
dwelling persons with Alzheimer’s disease, the CMAI
appears useful as an overall measure of behavioral dis-
turbances, but scoring by subscale does not seem applic-
able [29].
The Cornell scale for depression in dementia (CSDD)
is widely used for the screening of depressive symptoms
in dementia. The CSDD consists of 19 items, each rated
as 0 = absent, 1 =mild or intermittent or 2 = severe. The
scores of the individual items are summed, and a cut-off
of 8 or more indicates depression [30]. With a cut-off
value of > or = 6 the CSDD has a sensitivity and specificity
of 93% and 97%, respectively. It seems equally valid in de-
mented and non-demented populations [31]. The CSDD
Table 1 Assessment instruments
Instrument T0 T1 T2
Baseline variables X
Patient Mini Mental State Examination X X X
Neuropsychiatric Inventory X X X
Cohen-Mansfield Agitation Inventory X X X
Cornell Scale for Depression in Dementia X X X
Quality of life in Alzheimer’s disease X X X
Charlson Index X
Psychotropic drug use X X X
Informal
caregiver
Center for Epidemiological Studies
Depression Scale
X X X
General Health Questionnaire X X X
EuroQol X X X
Sense of Competence X X X
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will be administered by interviewing the informal care-
givers about their observations of the patients’ behavior.
Cognition
Cognition will be assessed by the Mini-Mental State
Examination (MMSE), which is the most widely used
screening instrument to detect cognitive impairment
[32]. It has a fair reliability and construct validity, with a
high sensitivity for moderately to severe cognitive im-
pairment and a lower sensitivity for mild cognitive im-
pairment [33]. It comprises items that test orientation,
attention, memory, language and constructive abilities.
An important bias in using the MMSE is the extensive use
of language, which leads to unreliable results in aphasic
patients and patients who are incapable of speaking the
local language [33].
Quality of life
The Quality of life in Alzheimer’s disease (Qol-AD) is
used to measure quality of life. It is an easy-to-use 13-
item instrument that covers physical health, energy, mood,
living situation, memory, family, marriage, friends, self as
a whole, ability to do chores around the house, ability to
do things for fun, money and life as a whole. Each of the
13 items is rated on a 4-point Likert scale, as follows: 1 -
‘poor’; 2 - ‘fair’; 3 - ‘good’ and 4 - ‘excellent’ [34,35]. Logs-
don found satisfactory validity and reliability, but a limited
use for patients with an MMSE score of less than 10 [36].
In other studies, the Qol-AD showed very good psycho-
metric properties, with satisfactory reliability and validity.
Furthermore it can be completed with people with a wide
range of severity of dementia [37-40].
Informal caregiver characteristics
The following general characteristics of the informal
caregivers will be collected at baseline (T0): age, gender,
marital state, socio-economic status/educational level
and profession.
Impact on informal caregiver
The psychological burden of caring for a patient with de-
mentia, measured using the sense of competence (SCQ),
will be the primary outcome for the informal caregivers.
The SCQ is based on the family-crisis model [41] and
derived from Zarit’s Burden Interview [42]. This inter-
view was developed for informal caregivers of patients
diagnosed with dementia and consists of 27-items that
are rated on a 5-point scale, as follows: 1 ‘yes, completely
agrees’, 2 ‘yes, agrees’, 3 ‘on the one hand agrees but on
the other hand disagrees’, 4 ‘no, disagrees’ and 5 ‘no,
completely disagrees’ [43,44]. The SCQ consists of the
following three subscales: 1. satisfaction with the elderly
person as the recipient of care (7 items; range 7–35;
Cronbach’s alpha = 0.55); 2. satisfaction with one’s own
performance as a caregiver (12 items; range 12–60;
Cronbach’s alpha = 0.63); and 3. consequences of in-
volvement in care for the personal life of the caregiver
(8 items; range 8–40; Cronbach’s alpha = 0.50). For each
dimension, higher scores indicate a better sense of
competence. Overall sum-scores range from 27 to 135
[43,45,46]. The validity and usefulness of the SCQ
when applied to informal caregivers of older adults
with dementia symptoms (i.e., cognitive impairment, pre-
diagnostic dementia or dementia in its early stages) has
also been studied. The 3 subscales of the SCQ showed
good homogeneity and feasibility, but their construct val-
idity was insufficient. Only the subscale ‘consequences of
involvement in care for the personal life of the caregiver’
was found to be partly valid [44].
Depression
The Center for Epidemiological Studies Depression Scale
(CES-D) is a 20-item instrument that assesses the fre-
quency of experienced depressive symptoms within the
past week. The items are rated on a 4-point Likert scale
from 0 ‘rarely or none of the time to 3 ‘most or all of the
time’. Scores range from 0 to 60. A score of 16 or over
has been clinically associated with a greater risk of de-
pression [47,48]. Test-retest reliability at 3-month inter-
vals over a 12-month period for the CES-D was reported
to be 0.49–0.54 [47]. This instrument has been widely
used in dementia research and most of these studies
have used the CES-D total score [49-54]. The original
4-factor model of item responses is informative for identi-
fying meaningful clusters of depressive symptoms in de-
mentia caregivers [55,56].
General health
The General Health Questionnaire (GHQ-12) is a 12-
item questionnaire, with sum scores ranging from 0 to
36 (lower scores indicate better health status) [57]. It is a
widely used self-report instrument, that is assumed to
cover a wide range of common psychiatric morbidity, in
particular, anxiety and depressive disorders. The GHQ
was originally developed as a screening instrument for
use in general practice. Several short-form versions (30,
28, 20 and 12 items) of the original 60-item version have
been developed. Good psychometric properties have
been reported, in particular for the GHQ-12 [58,59].
EuroQol (EQ-5D) is a self-administered questionnaire
in which respondents evaluate their health state “today”
on the following 5 dimensions: mobility, self-care, usual
activities, pain/discomfort and anxiety/depression. A
1-to-3 scale is used for each dimension, representing no
problem, some problem, or extreme problem for the sub-
ject to engage in the activity alone; for the pain and
anxiety items, the three ratings relate to the severity
of symptoms. The instrument also has a visual analog
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scale “thermometer” (VAS), a 20-cm scale anchored at 0
“worse imaginable health state” and 100 “best imaginable
health state” [60]. The EQ-5D has been translated into
several languages and has been validated and employed in
many studies on general populations and subjects with
mild dementia [61,62].
Data analysis
All data will be analyzed using the Statistical Package for
Social Science 20.0 (SPSS 20.0). Descriptive analysis will
be used for general patient and caregiver characteristics,
disease characteristics and time to death or time to
institutionalization. Only data of patients and caregivers
with complete follow-up of 18 months will be used for data
analysis. Patient and caregiver characteristics of with-
drawals (subjects included, but no data received) and losses
to follow-up/drop-outs will be described and compared
with the patients and caregivers who will complete follow-
up. If patients become institutionalized during follow-up,
data collection will be continued with the same informant/
informal caregiver. Patient and caregiver characteristics,
baseline MMSE and baseline NPI total scores will be com-
pared to the non-institutionalized subjects. If these data
are comparable, then they will be used for data analysis.
The frequency (point and cumulative prevalence), cu-
mulative incidence, and persistence of symptoms are
expressed as the percentage of patients with scores greater
than 3 on any item of the NPI, at study onset and/or at
any follow-up evaluations. Point prevalence will be defined
as the proportion of patients with specific symptoms at
each assessment. The accumulative prevalence will be
defined as the proportion of patients developing a
specific symptom on at least one assessment over the
18-month study period. The cumulative incidence will
be rated as the proportion of patients who are symptom-
free at baseline but develop the specific symptom at sub-
sequent assessments. A symptom will be considered as
persistent if it was present on at least two subsequent
assessments, regardless of time of first manifestation of
the symptom. In addition, the proportion of patients with
persistence of symptoms during all 3 assessments will
be calculated.
Univariate analysis will be performed to identify deter-
minants of NPS in patients with dementia in primary
care as dependent variable for each assessment. Univariate
analysis will also be performed to identify determinants
of caregiver distress as dependent variable. Independent
determinants will be multicomponent collaborative care
(CONCERN), single component dementia CM, NPS at
baseline, cognition and use of health care services (home
care: nursing and domestic; use of day care services).
All determinants will then be tested in a multivariate
regression analysis to determine their unique contribu-
tion to the course of NPS and informal caregiver distress.
To take into account the clustering of patients with
dementia/informal caregivers in general practices and
the repeated measurements within patients random coeffi-
cient analyses will be used.
According to the National Public Health Compass, de-
veloped and coordinated at the Dutch National Institute
of Public Health and the Environment, absolute preva-
lence of patients with dementia in registrations of gen-
eral practices is 20 per general practice per year. Based
on their interest in participating 18 practices were se-
lected. With an assumed response rate of 50% and loss
to follow-up rate of 30% after 18 months, the expected
study population will be 126 patients with dementia. In
analysis of causal influences in observational data, as a
rule of thumb 1 candidate predictor can be studied for
every 10 patients. For logistic regression this rule can be
relaxed to 5–9 events per candidate predictor [63]. The
assumed prevalence rate of NPS in primary care is 60%
[16,17]. The number of independent variables in this
study will be 7. Therefore 126 patients with dementia
will suffice for the regression analyses.
Proportions (prevalence, incidence, persistence) can be
estimated with absolute precision of 10% and a confi-
dence level of 95% taking into account design effect of
1.25 based on an intraclass correlation coefficient (ICC)
of 0.05 and a mean cluster size of 6, assuming a conser-
vative estimate of anticipated proportion of 50%.
Discussion
To our knowledge, this study is the first to focus on the
course of NPS in patients with dementia and informal
caregiver distress in primary care. All selected outcome
measures have been proven and validated. The data will
be collected by one research assistant. Therefore, meas-
urement inaccuracies will be minimal.
This study has some limitations. Only 19% of the GPs
we invited are willing to participate. This might limit the
generalizability of the findings. Data will be collected at
baseline, after 9 months and after 18 months. Variations
in course between two successive assessments will be
unknown. Because this is a naturalistic study, the course
of NPS can be influenced by psychosocial and pharma-
ceutical interventions that we will not specifically assess
in this study. Furthermore, we will select patients coded
with dementia as classified in the ICPC code P70 and
P20. Dementia in these patients is not necessarily de-
fined with international criteria and Dutch consensus
guidelines, causing a risk of bias. In the different general
practices variability exists in the usage of the classifi-
cation according to ICPC in the electronic medical files.
However, because GPs often wait before diagnosing de-
mentia, we expect that this bias will be small. On the
other hand, this may bias the sample towards a more se-
vere spectrum of illness.
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The current study will provide more detailed informa-
tion about consequences of NPS for the quality of life of
both patients and informal caregivers as well as the in-
fluence of NPS on depressive symptoms and experienced
health state of the caregiver, which is clinically import-
ant. The data will help GPs and other professionals in
planning follow-up visits and in the timing of offering
psycho-education, psychosocial interventions and the
provision of care. It will enlarge their awareness of NPS in
their patients with dementia. An individually tailored ap-
proach for patients with dementia and their informal care-
givers may offer more and better treatment opportunities.
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